TrialEuropean journal of clinical pharmacology2005

The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor.

Nenad Sarapa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.